However, the results of other studies indicated that TGFBI promoted the metastatic potential of ovarian cancer cells by promoting their motility, invasion, and adhesion to peritoneal cells [90] and that overall survival (OS) was significantly shorter in serous-epithelial ovarian cancer patients whose tumours expressed TGFBI [91]. The gene discussed is TGFBI; the disease is neoplasm.